All News

Current regulation and governance of UK clinical trials hold up medical advances, says the Academy of Medical Sciences.

Index Ventures raised $400 million dollars in its last fund, of which about half will be invested in life science start-ups. Senior partner, Francesco de Rubertis says personalised medicine will take a large share of this.

Human capital, infrastructure and good governance may provide support for innovation and economic growth, but they don’t guarantee it

Science|Business launches its revamped online portal for European research and innovation.